Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Operating activities:
Net (loss) income	$ (7,853)	$ 6,501
Adjustments to reconcile net (loss) income to net cash provided (used) by operating activities:
Depreciation and amortization	11,004	9,734
Restricted stock compensation	676	753
Asset Impairment Charges	0	4,222
Contingent consideration write-off	0	(7,950)
Write off of Deferred Debt Issuance Cost	8,340	0
Deferred Income Tax Expense (Benefit)	(210)	2,915
payments for hedge, operating activities	(793)	0
Other noncash items	(166)	(174)
Changes in operating assets and liabilities:
Accounts receivable	(151)	(17,614)
Inventories	4,336	(14,691)
Prepaid expenses and other assets	1,507	(263)
Current income taxes	(1,762)	545
Accounts payable	(817)	(4,580)
Accrued expenses	829	3,033
Net cash provided (used) by operating activities	14,940	(17,569)
Investing activities:
Additions to property, plant and equipment	(7,785)	(17,873)
Proceeds from sale of property, plant, and equipment	981	1,880
Net cash used by investing activities	(6,804)	(15,993)
Financing activities:
Proceeds from issuance of debt	250,000	6,136
Principal payments on long-term debt and notes payable	(224,227)	(2,376)
Advances on revolving line of credit	52,500	69,500
Payments on revolving line of credit	(79,500)	(41,500)
Payments of Debt Issuance Costs	(6,692)	0
Other, net	(28)	9
Net cash (used) provided by financing activities	(7,947)	31,769
Net increase (decrease) in cash and cash equivalents	189	(1,793)
Cash and cash equivalents, beginning of period	1,572	4,347
Cash and cash equivalents, end of period	1,761	2,554
Supplemental disclosure of noncash transactions:
Defined contribution plan funding in Company stock	$ 848	$ 901